SCHEMBL5589404

SCHEMBL5589404

CC(F)(F)c1cccc(O)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.50
ALDH1A1 P00352 4/20 0.48
TDP1 Q9NUW8 3/20 0.48
TSHR P16473 1/20 0.48
LMNA P02545 3/20 0.48
HPGD P15428 3/20 0.48
ALOX15 P16050 3/20 0.48
HSD17B10 Q99714 3/20 0.48
EGFR P00533 2/20 0.48
FYN P06241 2/20 0.48
MMP9 P14780 2/20 0.48
RECQL P46063 2/20 0.48
ADAMTS4 O75173 1/20 0.48
CA1 P00915 1/20 0.48
MMP2 P08253 1/20 0.48
MMP8 P22894 1/20 0.48
CA6 P23280 1/20 0.48
CDK2 P24941 1/20 0.48
MMP12 P39900 1/20 0.48
ADAMTS5 Q9UNA0 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9495142 0.86 CA2 (0.54) CA2ALDH1A1TDP1TSHRLMNA
SCHEMBL5515511 0.81 ALDH1A1 (0.52) CA2ALDH1A1TDP1TSHRLMNA
SCHEMBL986029 0.81 CA2 (0.54) CA2ALDH1A1TDP1TSHRLMNA
SCHEMBL30504750 0.81 CA2 (0.76) CA2ALDH1A1TDP1TSHRLMNA
SCHEMBL36109 0.81 CA2 (0.76) CA2ALDH1A1TDP1TSHRLMNA
SCHEMBL23861438 0.80 CA2 (0.48) CA2ALDH1A1TDP1TSHRLMNA
SCHEMBL7799140 0.80 ALDH1A1 (0.58) CA2ALDH1A1TDP1TSHRLMNA
Ammonia Solution, Strong SCHEMBL30638319 0.79 CA2 (0.73) CA2ALDH1A1TDP1TSHRLMNA
SCHEMBL5589842 0.79 CA2 (0.52) CA2ALDH1A1TDP1TSHRLMNA
SCHEMBL28456518 0.79 CA2 (0.52) CA2ALDH1A1TDP1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 CA2 2455/4885ALDH1A1 2181/4885TDP1 3761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.